Company News: Boehringer Ingelheim

Share this article:
The Boehringer Ingelheim-backed Drive4COPD awareness campaign is getting a big response through its use of social media, the company said. The campaign, which launched two weeks ago, has generated 27,000 completions of a validated five-question screener available at Drive4COPD.com, along with 1,400 Facebook fans, 25,000 clicks on campaign images at photo sharing site Flickr, 140,000 search results and 14,500 Twitter followers who've been exposed to some 50 Tweets from the campaign's celebrity ambassadors.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.